Letter: Pathogenesis of tumour necrosis factor-alpha antagonists-induced psoriasiform lesions

Alimentary Pharmacology and Therapeutics

Volumn 36, Issue 1, 2012, Pages 77-78

  Denadai, R ^a   Teixeira, F V ^a   Saad Hossne, R ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; MYXOVIRUS RESISTANCE PROTEIN A; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE ASSOCIATION; DISEASE EXACERBATION; DOWN REGULATION; ENVIRONMENTAL FACTOR; GENETIC PREDISPOSITION; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATORY CELL; INTRACELLULAR SIGNALING; LETTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; PSORIASIS; UPREGULATION;

ANTI-INFLAMMATORY AGENTS; DERMATOLOGIC AGENTS; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; METHOTREXATE; PSORIASIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84861810469     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2012.05126.x     Document Type: Letter

References (10)

1. Buisson A, Cuny JF, Barbaud A, et al,. Methotrexate for psoriasiform lesions associated with anti-tumour necrosis factor therapy in inflammatory bowel disease. Aliment Pharmacol Ther 2012; 35: 1175-80.
2. Collamer AN, Battafarano DF,. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis. Semin Arthritis Rheum 2010; 40: 233-40.
3. Seneschal J, Milpied B, Vergier B, et al,. Cytokine imbalance with increased production of interferon-alpha in psoriasiform eruptions associated with antitumour necrosis factor-alpha treatments. Br J Dermatol 2009; 161: 1081-8.
4. Albanesi C, Scarponi C, Bosisio D, et al,. Immune functions and recruitment of plasmacytoid dendritic cells in psoriasis. Autoimmunity 2010; 43: 215-9.
5. Palucka AK, Blanck JP, Bennett L, et al,. Cross-regulation of TNF and IFN-alpha in autoimmune diseases. Proc Natl Acad Sci USA 2005; 102: 3372-7.
6. Laga AC, Vleugels RA, Qureshi AA, Velazquez EF,. Histopathologic spectrum of psoriasiform skin reactions associated with tumor necrosis factor-alpha inhibitor therapy. A study of 16 biopsies. Am J Dermatopathol 2010; 32: 568-73.
7. de Gannes GC, Ghoreishi M, Pope J, et al,. Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions. Arch Dermatol 2007; 143: 223-31.
8. Glenn CJ, Kobraei KB, Russo JJ,. New-onset psoriasis associated with adalimumab: a report of two cases. Dermatol Online J 2011; 17: 15.
9. Sfikakis PP,. The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions. Curr Dir Autoimmun 2010; 11: 180-210.
10. Sherlock M, Walters T, Zachos M, et al,. Infliximab-induced psoriasis in pediatric Crohn disease; experience of this paradoxical skin manifestation at a tertiary centre and a potential association with a variation in the IL-23r gene. Gastroenterology 2009; 136 (Suppl. 1): A671.